Seres Therapeutics, Inc.
MCRBReported to SECin USCIK 0001609809Filings at SEC EDGAR
No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 31. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
The most recent filings
Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.
| Filed by | Type | Value | Reported | Filed by | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| Brady KellySee Remarks | Option exercise | nothing paid91 shares | Aug 18, 2026 | Brady KellySee Remarks | nothing paid | Option exercise | 91 | Aug 18, 2026 |
| Brady KellySee Remarks | Option exercise | nothing paid90 shares | Aug 18, 2026 | Brady KellySee Remarks | nothing paid | Option exercise | 90 | Aug 18, 2026 |
| Brady KellySee Remarks | Open-market sell | $29164 shares | Aug 18, 2026 | Brady KellySee Remarks | $291 | Open-market sell | 64 | Aug 18, 2026 |
| Brady KellySee Remarks | Option exercise | —181 shares | Aug 18, 2026 | Brady KellySee Remarks | — | Option exercise | 181 | Aug 18, 2026 |
| Shaff Eric D.— | Option exercise | nothing paid332 shares | Aug 18, 2026 | Shaff Eric D. | nothing paid | Option exercise | 332 | Aug 18, 2026 |